Seattle Genetics

News

T-cells attacking cancer cell illustration of microscopic photos

‘Trojan horse’ cancer drug shows promise in multiple tumour ...

A new type of cancer drug that acts as a ‘Trojan horse’ to get inside tumour cells has shown promise in patients with six different cancer types.

News

Seattle Genetics and Astellas gain Breakthrough Designation ...

The FDA has granted Breakthrough Therapy Designation to enfortumab vedotin, an antibody-drug conjugate (ADC) being developed by Seattle Genetics and Astellas.

Partner Content

Partner Content

Exclusive Speaker Interview from Seattle Genetics for SMi’s ...

Interview from Seattle Genetics

News

Seattle, Takeda aim for first line Adcetris use

Seattle CEO hopes Adcetris will be standard of care.

News

Seattle Genetics halts trials of latest ADC after safety war...

Monitoring committee concerned about high death rates.

News

Seattle Genetics leukaemia trial on hold after 4 deaths

FDA concerned over potential liver toxicity.

‘Trojan horse’ cancer drug shows promise in multiple tumour ...

Seattle Genetics and Astellas gain Breakthrough Designation ...

Exclusive Speaker Interview from Seattle Genetics for SMi’s ...

Seattle, Takeda aim for first line Adcetris use

Seattle Genetics halts trials of latest ADC after safety war...

Seattle Genetics leukaemia trial on hold after 4 deaths

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

Seattle Genetics

Editor's Picks